New PET scan technique for detecting lymphoma and myeloma
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study tests a newer type of PET/MR scan using a special tracer (68Ga-Pentixafor) to see if it can find lymphoma and multiple myeloma lesions better than the standard scan. The scan is painless and takes about 30 minutes, and it might help doctors see the cancer more clearly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be able to care for yourself (performance status ECOG less than 2).
- You must have a new diagnosis (or high suspicion) of non-Hodgkin lymphoma or multiple myeloma, confirmed by biopsy or other pathology tests.
- You must have already had a standard PET scan (FDG PET/CT or PET/MR) within the past week at the same hospital.
- You must not be pregnant or breastfeeding, and must have no severe liver or kidney problems, no other active cancer, and no metal implants that would make an MRI unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging method that uses a special tracer to find multiple myeloma cells in the body. It may help doctors see the disease more clearly and guide treatment.
This trial compares a new type of PET/MR scan (using a radioactive tracer called Ga-68 PentixaFor) with standard imaging to see if it can better detect multiple myeloma at diagnosis and during follow-up. It may help improve staging and treatment planning.
This study tests a new imaging method called CXCR4 PET/CT that may help doctors better see and understand lymphomas (a type of blood cancer). It is for people who are newly diagnosed or suspected of having lymphoma and have already had a standard PET/CT.
This study tests a new PET scan method (using a special tracer called 18F-Pentixafor) to see if it can better find and track blood cancers. It may help your doctors get more detailed images with less radiation.
This early study tests a new PET scan tracer (a radioactive imaging agent) that may light up a cell marker called CXCR4 in certain blood and solid tumor cancers. It may help doctors see where cancers are and how much CXCR4 they have, which could guide future treatments.
This study uses a special PET scan to look for multiple myeloma in your body. It may help doctors see where the disease is and how active it is.
Hear when a new Non Hodgkin's Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.